Skip to main content

Home / Publications / Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group

RECOVERY Collaborative Group

DOI: 10.1016/S0140-6736(21)00676-0
Type: Clinical TrialJournal ArticleNon-U.S. Gov'tPhase IIPhase IIIRandomized Controlled TrialResearch Support
Journal: LANCET
Publication Date: 2021-05-01